107 related articles for article (PubMed ID: 3352538)
1. Prognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis.
Rodary C; Rey A; Olive D; Flamant F; Quintana E; Brunat-Mentigny M; Otten J; Voute PA
Med Pediatr Oncol; 1988; 16(2):71-7. PubMed ID: 3352538
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of alveolar rhabdomyosarcoma in childhood. An International Society of Pediatric Oncology study.
Reboul-Marty J; Quintana E; Mosseri V; Flamant F; Asselain B; Rodary C; Zucker JM
Cancer; 1991 Aug; 68(3):493-8. PubMed ID: 2065269
[TBL] [Abstract][Full Text] [Related]
3. Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies.
Rogers T; Minard-Colin V; Cozic N; Jenney M; Merks JHM; Gallego S; Devalck C; Gaze MN; Kelsey A; Oberlin O; Stevens M; Spicer RD; Bergeron C; Martelli H
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28205365
[TBL] [Abstract][Full Text] [Related]
4. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop.
Rodary C; Gehan EA; Flamant F; Treuner J; Carli M; Auquier A; Maurer H
Med Pediatr Oncol; 1991; 19(2):89-95. PubMed ID: 2011101
[TBL] [Abstract][Full Text] [Related]
6. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
Jenney M; Oberlin O; Audry G; Stevens MC; Rey A; Merks JH; Kelsey A; Gallego S; Haie-Meder C; Martelli H
Pediatr Blood Cancer; 2014 Feb; 61(2):217-22. PubMed ID: 23997024
[TBL] [Abstract][Full Text] [Related]
7. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors in rhabdomyosarcomas in childhood. Study carried out with 253 children registered by the International Society of Pediatric Oncology].
Rodary C; Rey A; Rezvani A; Flamant F
Bull Cancer; 1988; 75(2):213-23. PubMed ID: 3359065
[TBL] [Abstract][Full Text] [Related]
9. Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.
Rodeberg DA; Stoner JA; Garcia-Henriquez N; Randall RL; Spunt SL; Arndt CA; Kao S; Paidas CN; Million L; Hawkins DS
Cancer; 2011 Jun; 117(11):2541-50. PubMed ID: 24048802
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
Lawrence W; Anderson JR; Gehan EA; Maurer H
Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
[TBL] [Abstract][Full Text] [Related]
11. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O
J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225
[TBL] [Abstract][Full Text] [Related]
12. Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology.
Martelli H; Oberlin O; Rey A; Godzinski J; Spicer RD; Bouvet N; Haie-Meder C; Terrier-Lacombe MJ; Sanchez de Toledo J; Spooner D; Sommelet D; Flamant F; Stevens MC
J Clin Oncol; 1999 Jul; 17(7):2117-22. PubMed ID: 10561266
[TBL] [Abstract][Full Text] [Related]
13. Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study.
Lobeck I; Dupree P; Karns R; Rodeberg D; von Allmen D; Dasgupta R
J Pediatr Surg; 2017 Apr; 52(4):614-617. PubMed ID: 27642084
[TBL] [Abstract][Full Text] [Related]
14. [The treatment results in children with malignant mesenchymal tumors according to the protocols of the International Society of Pediatric Oncology (SIOP)].
López Pérez J; Melero Moreno C; Vivanco Martínez JL; Torres Valdivieso MJ; Cela de Julián E
An Esp Pediatr; 1996 Jun; 44(6):557-60. PubMed ID: 8849098
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
Oberlin O; Rey A; Sanchez de Toledo J; Martelli H; Jenney ME; Scopinaro M; Bergeron C; Merks JH; Bouvet N; Ellershaw C; Kelsey A; Spooner D; Stevens MC
J Clin Oncol; 2012 Jul; 30(20):2457-65. PubMed ID: 22665534
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary collaborative therapy for 30 children with orbital rhabdomyosarcoma.
Ge X; Huang DS; Shi JT; Ma JM
Asian Pac J Cancer Prev; 2013; 14(8):4641-6. PubMed ID: 24083717
[TBL] [Abstract][Full Text] [Related]
17. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
[TBL] [Abstract][Full Text] [Related]
18. Parameningeal rhabdomyosarcoma: results of an international workshop.
Benk V; Rodary C; Donaldson SS; Flamant F; Maurer H; Treuner I; Carli M; Gehan E
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):533-40. PubMed ID: 8948336
[TBL] [Abstract][Full Text] [Related]
19. Childhood rhabdomyosarcoma: experience of the Children's Solid Tumour Group.
Kingston JE; McElwain TJ; Malpas JS
Br J Cancer; 1983 Aug; 48(2):195-207. PubMed ID: 6882660
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma.
Mazzoleni S; Bisogno G; Garaventa A; Cecchetto G; Ferrari A; Sotti G; Donfrancesco A; Madon E; Casula L; Carli M;
Cancer; 2005 Jul; 104(1):183-90. PubMed ID: 15895378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
